- Report
- January 2023
- 229 Pages
Middle East, Africa
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- January 2023
- 152 Pages
North America
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- January 2023
- 151 Pages
Europe
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- January 2023
- 183 Pages
Asia Pacific
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- November 2022
- 291 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- April 2023
- 111 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- August 2022
- 120 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- August 2022
- 120 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- May 2020
- 111 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- August 2023
- 75 Pages
India
From €3384EUR$3,500USD£2,906GBP
- Report
- December 2022
- 115 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- September 2022
- 145 Pages
Global
From €4109EUR$4,250USD£3,529GBP
- Report
- May 2021
- 120 Pages
Global
From €2417EUR$2,500USD£2,076GBP
- Drug Pipelines
- June 2020
- 48 Pages
Global
From €1934EUR$2,000USD£1,661GBP
- Report
- December 2023
- 80 Pages
France
From €2509EUR$2,595USD£2,155GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €2509EUR$2,595USD£2,155GBP
- Report
- December 2023
- 80 Pages
South Korea
From €2509EUR$2,595USD£2,155GBP
- Report
- December 2023
- 80 Pages
Germany
From €2509EUR$2,595USD£2,155GBP
- Report
- December 2023
- 80 Pages
India
From €2509EUR$2,595USD£2,155GBP
- Report
- December 2023
- 80 Pages
United Kingdom
From €2509EUR$2,595USD£2,155GBP
The antimalarial market is a subset of the infectious diseases drugs market, which focuses on the treatment and prevention of malaria. Antimalarial drugs are used to treat and prevent the spread of the Plasmodium parasite, which is responsible for the disease. These drugs are typically administered orally, intravenously, or intramuscularly, depending on the severity of the infection. Common antimalarial drugs include chloroquine, artemisinin, and mefloquine.
In addition to antimalarial drugs, the market also includes insecticides, insect repellents, and other preventive measures. These products are used to reduce the risk of infection by controlling the mosquito population, which is the primary vector for the Plasmodium parasite.
Notable companies in the antimalarial market include GlaxoSmithKline, Sanofi, Novartis, and Merck. These companies produce a variety of antimalarial drugs, insecticides, and other preventive measures. Show Less Read more